SEC14L2
SEC14-like protein 2
Also known as: C22orf6, KIAA1186, KIAA1658, S14L2_HUMAN, SPF, TAP, TAP1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O76054
- Gene
- SEC14L2
- Ensembl
- ENSG00000100003
- Chromosome
- 22
- Canonical length
- 403 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes a cytosolic protein which belongs to a family of lipid-binding proteins including Sec14p, alpha-tocopherol transfer protein, and cellular retinol-binding protein. The encoded protein stimulates squalene monooxygenase which is a downstream enzyme in the cholesterol biosynthetic pathway. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Oct 2008]
Canonical amino-acid sequenceUniProt
403 residues, UniProt reviewed canonical sequence.
>O76054|SEC14L2
1 MSGRVGDLSP RQKEALAKFR ENVQDVLPAL PNPDDYFLLR WLRARSFDLQ KSEAMLRKHV
61 EFRKQKDIDN IISWQPPEVI QQYLSGGMCG YDLDGCPVWY DIIGPLDAKG LLFSASKQDL
121 LRTKMRECEL LLQECAHQTT KLGRKVETIT IIYDCEGLGL KHLWKPAVEA YGEFLCMFEE
181 NYPETLKRLF VVKAPKLFPV AYNLIKPFLS EDTRKKIMVL GANWKEVLLK HISPDQVPVE
241 YGGTMTDPDG NPKCKSKINY GGDIPRKYYV RDQVKQQYEH SVQISRGSSH QVEYEILFPG
301 CVLRWQFMSD GADVGFGIFL KTKMGERQRA GEMTEVLPNQ RYNSHLVPED GTLTCSDPGI
361 YVLRFDNTYS FIHAKKVNFT VEVLLPDKAS EEKMKQLGAG TPKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SEC14L2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 228 nTPM
Expression across tissuesHPA
Tissue
- liver: 228 nTPM
- epididymis: 81 nTPM
- retina: 60 nTPM
- prostate: 49 nTPM
- choroid plexus: 46 nTPM
- breast: 42 nTPM
Single-cell type
- müller glia: 89 nCPM
- astrocytes: 68 nCPM
- rod photoreceptor cells: 58 nCPM
- hepatocytes: 55 nCPM
- retinal pigment epithelial cells: 55 nCPM
- esophageal apical cells: 53 nCPM
Immune cell
- naive CD4 T-cell: 3.8 nTPM
- naive CD8 T-cell: 2.7 nTPM
- memory CD4 T-cell: 1.4 nTPM
- total PBMC: 0.8 nTPM
- T-reg: 0.7 nTPM
- gdT-cell: 0.5 nTPM
Brain region
- medulla oblongata: 79 nTPM
- basal ganglia: 73 nTPM
- thalamus: 71 nTPM
- hypothalamus: 66 nTPM
- midbrain: 65 nTPM
- cerebral cortex: 60 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SEC14L2.
Disease | ImmuneIEDB
Conditions an epitope on SEC14L2 was assayed in.
- ankylosing spondylitis T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.94
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.99
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SEC14L2 as an antibody target. Whether an autoantibody or antibody against SEC14L2 could matter depends on whether native SEC14L2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SEC14L2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SEC14L2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...